Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemiaBETTICHER, D. C; RATSCHILLER, D; CERNY, T et al.Annals of oncology. 1998, Vol 9, Num 7, pp 721-726, issn 0923-7534Article

Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemiaBETTICHER, D. C; SCHMITZ, S.-F. H; RATSCHILLER, D et al.British journal of haematology. 1997, Vol 99, Num 2, pp 358-363, issn 0007-1048Article

High levels of circulating CD34+ cells at autologous stem cell collection are associated with favourable prognosis in multiple myelomaRASCHLE, J; RATSCHILLER, D; MANS, S et al.British journal of cancer. 2011, Vol 105, Num 7, pp 970-974, issn 0007-0920, 5 p.Article

Cyclin dl overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survivalRATSCHILLER, D; HEIGHWAY, J; GUGGER, M et al.Journal of clinical oncology. 2003, Vol 21, Num 11, pp 2085-2093, issn 0732-183X, 9 p.Article